Burke Steven Keith

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$119,220.00
Insider Sells Quantity
13
Insider Sells Sum
$247,622.71

Insider Activity of Burke Steven Keith

According to the SEC Form 4 filings, Burke Steven Keith, being in a position of

  1. SVP, Chief Medical Officer at Akebia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 39847 shares for $64,887,
    over all time since 2019-11-20, has bought 27000 shares for $96,660, and sold 177960 shares for $247,623.

The largest purchase of all time was on 2019-11-20 and amounted to 27000 shares of Akebia Therapeutics, Inc. for $96,660.

The largest sale of all time was on 2023-05-16 and amounted to 63567 shares of Akebia Therapeutics, Inc. for $67,890.

Biography of Burke Steven Keith

No biography is available at this moment.

2024-02-29SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,169
0.0038%
$1.58$11,327-12.74%
2024-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
8,367
0.0041%
$1.52$12,718-16.46%
2024-02-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
24,311
0.0133%
$1.68$40,842-19.3%
2023-08-25SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
27,000
0.0145%
$1.15$31,050+9.13%
2023-05-16SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
63,567
0.035%
$1.07$67,890+20%
2023-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
14,123
0.0074%
$0.88$12,393+23.5%
2023-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,539
0.0041%
$0.81$6,131+38.48%
2022-08-31SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
1,147
0.0006%
$0.36$416+91.62%
2022-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,656
0.0043%
$2.17$16,619-80.93%
2022-02-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,400
0.0041%
$2.15$15,946-81.02%
2021-08-31SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
1,042
0.0006%
$2.83$2,949-32.14%
2021-04-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
1,081
0.0007%
$3.40$3,675-15.92%
2021-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,558
0.005%
$3.40$25,668-14.71%
2019-11-20PurchaseAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
27,000
0.0244%
$3.58$96,660+130.84%
2017-12-15PurchaseProtara Therapeutics, Inc.
TARA
SVP and Chief Medical Officer
12,000
0.0693%
$1.88$22,560+18.92%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.